CareCloud to Host Investor Meetings During the Week of the J.P. Morgan Healthcare Conference

CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that CareCloud’s president and chief executive officer, A. Hadi Chaudhry, and chief financial officer, Bill Korn, will host investor meetings on Jan. 10-11, 2023, at the same time and location as the 41st Annual J. P. Morgan Healthcare Conference in San Francisco.

As previously announced, on Tuesday, Jan. 10, 2023, CareCloud will change its Nasdaq ticker symbol from MTBC to CCLD. CareCloud’s Series A Preferred Stock ticker will also change from MTBCP to CCLDP, and the Series B Preferred Stock ticker will change from MTBCO to CCLDO.

To arrange a meeting with CareCloud leadership, investors should contact CareCloud’s investor relations firm, ICR Westwicke, at [e-mail].

About CareCloud

CareCloud (Nasdaq: MTBC, MTBCP and MTBCO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. Approximately 40,000 providers count on CareCloud to help improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, telehealth and patient experience management (PXM) at www.carecloud.com.

For additional information, please visit our website at www.carecloud.com.

Follow CareCloud on LinkedIn, Twitter and Facebook.

For additional information, please visit our website at www.carecloud.com. To view CareCloud’s latest investor presentations, read recent press releases, and listen to interviews with management, please visit ir.carecloud.com.

Company Contact:Bill KornChief Financial OfficerCareCloud, Inc. [e-mail]

Investor Contact:Asher DewhurstICR [e-mail]

Media Inquiries:Alexis FeinbergICR [e-mail]